Literature DB >> 12698366

Immunohistochemical study of the apoptotic mechanisms in the intestinal mucosa during children's coeliac disease.

Jirí Ehrmann1, Antonín Kolek, Rostislav Kod'ousek, Jana Zapletalová, Sona Lísová, Paul Gerard Murray, Jirí Drábek, Zdenek Kolár.   

Abstract

Mechanisms leading to morphological changes of the small intestine during coeliac disease (CD) are not yet completely recognized; however, two main processes have been suggested recently: remodeling of mucosa by matrix metalloproteinases, and mucosal atrophy by apoptosis. The aim of this study was analysis of the expression of proteins regulating apoptosis in the small intestine of children with active CD (ACD) and potential CD (PCD). Jejunal biopsies of 43 children with PCD and untreated ACD and 21 control samples were analyzed by means of standard indirect immunohistochemical technique for Fas, Fas ligand (Fas-L), tissue transglutaminase (tTG), Bcl-2, and glutathione S-transferase (GST) expression. We found significantly lower numbers of Fas-expressing enterocytes in the ACD patients than in PCD patients and controls. Similarly, the number of Fas-positive mucosal lymphocytes was decreased in ACD when compared with PCD. The number of Fas-L- and tTG-expressing enterocytes and mucosal lymphocytes was higher in both PCD and ACD. On the other hand, the number of Bcl-2-positive mucosal lymphocytes in PCD as well as ACD was significantly lower. The expression of tTG in extracellular matrix was significantly higher in PCD and ACD when compared with controls. Our results showed that Fas and/or Fas-L, Bcl-2, and tTG may be involved in apoptotic pathways leading to mucosal atrophy in children with CD. tTG changes are in agreement with the presumed role of this protein in the pathogenesis of CD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12698366     DOI: 10.1007/s00428-003-0794-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  50 in total

Review 1.  Apoptosis and gastrointestinal tract.

Authors:  R Ciccocioppo; A Di Sabatino; G Gasbarrini; G R Corazza
Journal:  Ital J Gastroenterol Hepatol       Date:  1999-03

2.  CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies.

Authors:  J Sträter; H Walczak; C Hasel; I Melzner; F Leithäuser; P Möller
Journal:  Cell Death Differ       Date:  2001-03       Impact factor: 15.828

Review 3.  Review: The role of glutathione in the regulation of apoptosis.

Authors:  A G Hall
Journal:  Eur J Clin Invest       Date:  1999-03       Impact factor: 4.686

4.  Role of tissue transglutaminase in gliadin binding to reticular extracellular matrix and relation to coeliac disease autoantibodies.

Authors:  H Uhlig; A A Osman; I D Tanev; J Viehweg; T Mothes
Journal:  Autoimmunity       Date:  1998       Impact factor: 2.815

5.  Increased small intestinal apoptosis in coeliac disease.

Authors:  S F Moss; L Attia; J V Scholes; J R Walters; P R Holt
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

Review 6.  The biochemistry of programmed cell death.

Authors:  G Kroemer; P Petit; N Zamzami; J L Vayssière; B Mignotte
Journal:  FASEB J       Date:  1995-10       Impact factor: 5.191

7.  High-resolution HLA-DQB1 typing using the polymerase chain reaction and sequence-specific primers.

Authors:  C G Mullighan; M Bunce; K I Welsh
Journal:  Tissue Antigens       Date:  1997-12

Review 8.  Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum.

Authors:  A Fasano; C Catassi
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

9.  Are intraepithelial lymphocytes in celiac mucosa responsible for inducing programmed cell death (apoptosis) in enterocytes? Histochemical demonstration of perforins in cytoplasmic granules of intraepithelial lymphocytes.

Authors:  M Shiner; M Eran; S Freier; J Faber; D Branski
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-10       Impact factor: 2.839

10.  Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells.

Authors:  A L Wagelie-Steffen; K Hartmann; H Vliagoftis; D D Metcalfe
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

View more
  3 in total

1.  Localization of tissue transglutaminase and N (epsilon)-(gamma) -glutamyl lysine in duodenal cucosa during the development of mucosal atrophy in coeliac disease.

Authors:  Wahiba Sakly; Badreddine Sriha; Ibtissem Ghedira; Françoise Bienvenu; Abdelkarim Ayadi; Mohamed Tahar Sfar; Alain Lachaux; Sadok Korbi; Jacques Bienvenu; Nicole Fabien
Journal:  Virchows Arch       Date:  2005-05-13       Impact factor: 4.064

2.  The redox state of transglutaminase 2 controls arterial remodeling.

Authors:  Jeroen van den Akker; Ed VanBavel; Remon van Geel; Hanke L Matlung; Bilge Guvenc Tuna; George M C Janssen; Peter A van Veelen; Wilbert C Boelens; Jo G R De Mey; Erik N T P Bakker
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

3.  Evaluation of crypt apoptotic bodies and apoptotic indices in pediatric celiac disease by routine staining and H2AX immunostaining.

Authors:  Sarah Adel Hakim; Dalia Abd El-Kareem
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.